Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.
Wei‐Fan Hsu(China Medical University), Cheng‐Yuan Peng(China Medical University), Wen‐Pang Su(China Medical University), Hung‐Yao Chen(China Medical University), Hung‐Wei Wang(China Medical University), Chi‐Ying Yang(China Medical University), Chun‐Che Lin(China Medical University), Hsueh‐Chou Lai(China Medical University), Po‐Heng Chuang(China Medical University), Jaw‐Town Lin(E-Da Hospital), Guan‐Tarn Huang(National Taiwan University Hospital), Ming-Hung Tsai(China Medical University), Cheng‐Kuo Chen(Asia University)
PubMed
January 1, 2020
Cited by 18
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022
|Gastroenterology|2024|449
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
|Annals of Internal Medicine|2016|364